Huang L, Wang X, Pei S, Li X, Dong L, Bian X, Sun H, Jin L, Hou H, Shi W, Zhang X, Zhang L, Zhao S, Chen X, Yin M*. Single-cell profiling reveals sustained immune infiltration, surveillance, and tumor heterogeneity in infiltrative BCC. J Invest Dermatol. 2023, S0022-202X(23)02066-3. doi: 10.1016/j.jid.2023.04.020.
Liu T, Fang ZY, Li X, Zhang LN, Cao DS*, Yin MZ*. Graph deep learning enabled spatial domains identification for spatial transcriptomics. Brief Bioinform. 2023 May 19, 24(3):bbad146. doi: 10.1093/bib/bbad146.
Guo Y, Jin L, Dong L, Zhang M, Kuang Y, Chen X*, Zhu W*, Yin M*. NHWD-1062 ameliorates inflammation and proliferation by the RIPK1/NF-κB/TLR1 axis in Psoriatic Keratinocytes. BIOMED PHARMACOTHER. 2023 Jun, 162: 114638. doi: 10.1016/j.biopha.2023.114638.
Hu R, Li Y, Guo Y, Li X, Du S, Liao M, Hou H, Sun H, Zhao S, Su J, Chen X*, Yin M*. BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacol Res. 2023 Jan, 187: 106609. doi: 10.1016/j.phrs.2022.106609.
Zeng F, Li Y, Meng Y, Sun H, He Y, Yin M*, Chen X*, Deng G*. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression. Exp Mol Med. 2023 Feb, 55(2): 364-376. doi: 10.1038/s12276-023-00936-y.
Li Z, Wu X, Chen S, Zhong J, Qiu X, Kpegah JKSK, Shi K, Can L, Zhang X, Yin M, Xie H, Su J, Zhou J. Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism. Genomics. 2023, 115 (3): 110634. doi: 10.1016/j.ygeno.2023.110634.
Hongyin Sun, Kui Deng, Xingchen Zhou, Dongsheng Cao, Yan Cheng, Xiang Chen, Mingzhu Yin*. A novel gene prognostic signature lymphocyte cytosolic protein 2 regulates melanoma progression by activating tumor-infiltrating CD8+ T-cells through the interferon regulatory factor 5 signaling pathway. Tumor Discovery 2023, 2(1), 318. https://doi.org/10.36922/td.318.
2022年
Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Morrow JS, Pusztai L, Rimm DL, Yin M*, Yan Q*. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. SCI TRANSL MED. 2022 Feb 2, 14 (630): eabf5473. doi: 10.1126/scitranslmed.abf5473.
Du S, Zeng F, Sun H, Liu Y, Han P, Zhang B, Xue W, Deng G*, Yin M*, Cui B*. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. BIOENGINEERED. 2022 Feb, 13 (2): 2498-2512. doi: 10.1080/21655979.2021.2017627.
Deng G, Zeng F, He Y, Meng Y, Sun H, Su J, Zhao S, Cheng Y, Chen X*, Yin M*. EEF2K silencing inhibits tumour progression through repressing SPP1 and synergizes with BET inhibitors in melanoma. Clinical and Translational Medicine. 2022 Feb, 12(2): e722. doi: 10.1002/ctm2.722.
Sun H, Huang B*, Cao J*, Yan Q*, Yin M*. Editorial: Epigenetic Regulation and Tumor Immunotherapy. Front Oncol. 2022 May 5, 12: 893157. doi: 10.3389/fonc.2022.893157.
Chen X, Wang K, Jiang S, Sun H, Che X, Zhang M, He J, Wen Y, Liao M, Li X, Zhou X, Song J, Ren X, Yi W, Yang J, Chen X, Yin M*, Cheng Y*. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. J Immunother Cancer. 2022 Mar, 10(3): e004026. doi: 10.1136/jitc-2021-004026.
Peng C, Jian X, Xie Y, Li L, Ouyang J, Tang L, Zhang X, Su J, Zhao S, Liu H, Yin M, Wu D, Wan M, Xie L, Chen X. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing. Br J Dermatol. 2022, 186(6): 997-1009. doi: 10.1111/bjd.20976.
Jiang R, Xu J, Zhang Y, Liu J, Wang Y, Chen M*, Chen X*, Yin M*. Ligustrazine alleviates psoriasis-like inflammation through inhibiting TRAF6/c-JUN/NFκB signaling pathway in keratinocyte. Biomed Pharmacother. 2022 Jun, 150: 113010. doi: 10.1016/j.biopha.2022.113010.
Farshidfar F, Rhrissorrakrai K, Levovitz C, Peng C, Knight J, Bacchiocchi A, Su J, Yin M, Sznol M, Ariyan S, Clune J, Olino K, Parida L, Nikolaus J, Zhang M, Zhao S, Wang Y, Huang G, Wan M, Li X, Cao J, Yan Q, Chen X, Newman AM, Halaban R. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat Commun. 2022,13(1): 898. doi: 10.1038/s41467-022-28566-4.
Fu X , Yin M*. Monocytes in tumor: from the sight of Single-cell analysis. Tumor Discovery. 2022, 1 (1): 1-19.
Yin M. Editor's foreword to the inaugural issue of Tumor Discovery. Tumor Discovery. 2022, 1 (1): 1-3.
Zhang X, Guo Y, Xiao T, Li J, Guo A, Lei L, Jin C, Long Q, Su J, Yin M, Liu H, Chen C, Zhou Z, Zhu S, Tao J, Hu S, Chen X, Peng C. CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathway. J Exp Clin Cancer Re, 2022, 41(1): 246. doi: 10.1186/s13046-022-02427-w.
Wang W, Liu X, Zhang Z, Yin M, Chen X, Zhao S, Wu L. Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma. OXID MED CELL LONGEV. 2022, 2022: 8172866. doi: 10.1155/2022/8172866.
Xiao Y, Jing D, Tang Z, Peng C, Yin M, Liu H, Chen X, Shen M. Serum lipids and risk of incident psoriasis: a prospective cohort study from the UK Biobank study and Mendelian randomization analysis. J Invest Dermatol, 2022, 142(12): 3192-3199.e12. doi: 10.1016/j.jid.2022.06.015.
Zhang Y, Xia J, Zhang J, Mao J, Chen H, Lin H, Jiang P, He X, Xu X, Yin M*, Wang Z*. Validity of a Soft and Flexible 3D-Printed Nissen Fundoplication Model in Surgical Training. International Journal of Bioprinting, 2022 Mar 23, 8 (2): 546. doi: 10.18063/ijb.v8i2.546.
Li X, Zhao S, Bian X, Zhang L, Lu L, Pei S, Dong L, Shi W, Huang L, Zhang X, Chen M, Chen X*, Yin M*. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. Theranostics, 2022 Oct 31, 12(17): 7532-7549. doi: 10.7150/thno.77528.
Wu S, Li X, Shang L, Wu L, Li T, Li P, Ji Z, Hou J, Yin M*, Xu W*. The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice. Acta Biochim Biophys Sin (Shanghai). 2022, 54(12): 1789-1800. doi: 10.3724/abbs.2022135.
2021年
Pei S, Yuan X, Zhang Z, Yao R, Xie Y, Shen M, Li B*, Chen X*, Yin M*. Convalescent Plasma to Treat COVID-19: Clinical Experience and Efficacy. Aging (Albany NY). 2021 Mar 18, 13 (6): 7758-7766. doi: 10.18632/aging.202795.
Zhu S, Guo Y, Zhang X, Liu H, Yin M, Chen X, Peng C. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 2021, 503: 240-248. doi: 10.1016/j.canlet.2020.11.018.
Vouga M, Favre G, Martinez-Perez O,......, Yin M, Haessig A, Ackermann S, Baud D, Panchaud A. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci Rep. 2021;11(1):13898. doi: 10.1038/s41598-021-92357-y.
Lu Y, Xiao Y, Yin MZ, Zhou XC, Wu LS, Chen WQ, Luo Y, Kuang YH, Zhu W. Polyethylene Glycol Ointment Alleviates Psoriasis-Like Inflammation Through Down-Regulating the Function of Th17 Cells and MDSCs. Front Med (Lausanne). 2021, 7: 560579. doi: 10.3389/fmed.2020.560579.
Dong L#, Pei S#, Ren Q, Fu S, Yu L, Chen H, Chen X*, Yin M*. Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns. Placenta. 2021, 111: 91-96. doi: 10.1016/j.placenta.2021.06.007.
Fu L, Yang ZY, Yang ZJ, Yin MZ, Lu AP, Chen X, Liu S, Hou TJ, Cao DS. QSAR-assisted-MMPA to expand chemical transformation space for lead optimization. Brief Bioinform. 2021, 22(5): bbaa374. doi: 10.1093/bib/bbaa374.
Yang ZY, Dong J, Yang ZJ, Yin M, Jiang HL, Lu AP, Chen X, Hou TJ, Cao DS. ChemFLuo: a web-server for structure analysis and identification of fluorescent compounds. Brief Bioinform. 2021, 22(4): bbaa282. doi: 10.1093/bib/bbaa282.
Guo Y, Shen M, Zhang X, Xiao Y, Zhao S, Yin M, Bu W, Wang Y, Chen X, Su J. Unemployment and Health-Related Quality of Life in Melanoma Patients During the COVID-19 Pandemic. Front Public Health. 2021, 9: 630620. doi: 10.3389/fpubh.2021.630620.
Yang ZY, Yang ZJ, Zhao Y, Yin MZ, Lu AP, Chen X, Liu S, Hou TJ, Cao DS. PySmash: Python package and individual executable program for representative substructure generation and application. Brief Bioinform. 2021, 22(5): bbab017. doi: 10.1093/bib/bbab017.
Hu R, Zhao S, Su J, Chen X*, Yin M*. Establishment of cultured primary acral melanoma cells and animal models for Chinese patients. Pigment Cell Melanoma Res. 2021 Nov, 34 (6): 1131-1137. doi: 10.1111/pcmr.12996.
Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, Chen X, Hou T, Cao D. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021, 49(W1): W5-W14. doi: 10.1093/nar/gkab255.
Jiang Y, Wang G, Mu H, Ma X, Wang Z, Lv Y, Zhang T, Xu J, Wang J, Li Y, Han J, Yang M, Wang Z, Zeng K, Jin X, Xue S, Yin M, Sun W, Hua Y, Cai Z. Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling. Front Oncol. 2021, 11: 642134. doi: 10.3389/fonc.2021.642134.
Liu N, Zhang J, Yin M, Liu H, Zhang X, Li J, Yan B, Guo Y, Zhou J, Tao J, Hu S, Chen X, Peng C. Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization. Mol Ther. 2021, 29(7): 2321-2334. doi: 10.1016/j.ymthe.2021.03.013.
Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, McGeary MK, Song E, Blenman KRM, Micevic G, Jessel S, Zhang Y, Yin M, Booth CJ, Jilaveanu LB, Damsky W, Sznol M, Kluger HM, Iwasaki A, Bosenberg MW, Yan Q. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. NATURE. 2021, 598 (7882): 682-687. doi: 10.1038/s41586-021-03994-2.
2020年
Hu R, Han C, Pei S, Yin M*, Chen X*. Procalcitonin Levels in COVID-19 Patients. Int J Antimicrob Agents. 2020 Aug, 56(2):106051. doi: 10.1016/j.ijantimicag.2020.106051.
Jin L, Liu P, Yin M, Zhang M, Kuang Y, Zhu W. RIPK1: A rising star in inflammatory and neoplastic skin diseases. J Dermatol Sci. 2020, 99(3): 146-151. doi: 10.1016/j.jdermsci.2020.06.001.
Yin M*, Guo Y, Hu R, Cai WL, Li Y, Pei S, Sun H, Peng C, Li J, Ye R, Yang Q, Wang N, Tao Y, Chen X, Yan Q. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nat Commun. 2020 Apr 14, 11(1): 1833. doi: 10.1038/s41467-020-15290-0.
Liu N, Qi M, Li K, Zeng W, Li J, Yin M, Liu H, Chen X, Zhang J, Peng C. CD147 Regulates Melanoma Metastasis via the NFAT1-MMP-9 Pathway. Pigment Cell Melanoma Res. 2020, 33(5): 731-743. doi: 10.1111/pcmr.12886.
Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020, 96: 467-474. doi: 10.1016/j.ijid.2020.05.055.
Deng G, Zeng F*, Zhang L*, Chen H*, Chen X*, Yin M*. Characteristics of Pregnant COVID-19 Patients with Liver Injury. J Hepatol. 2020 Oct, 73(4): 989-991. doi: 10.1016/j.jhep.2020.06.022.
Li Z#, Yin M#, Zhang H, Ni W, Pierce RW, Zhou HJ, Min W. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis. Circ Res. 2020 Feb 14, 126(4): 471-485. doi: 10.1161/CIRCRESAHA.119.315769.
Xue Y, Liu Y, Bian X, Zhang Y, Li Y*, Zhang Q*, Yin M*. miR-205-5p Inhibits Psoriasis-Associated Proliferation and Angiogenesis: Wnt/β-catenin and Mitogen-Activated Protein Kinase Signaling Pathway Are Involved. J Dermatol.2020, 47(8): 882-892. doi: 10.1111/1346-8138.15370.
Chen XS, Wang KS, Guo W, Li LY, Yu P, Sun XY, Wang HY, Guan YD, Tao YG, Ding BN, Yin M, Ren XC, Zhang Y, Chen CS, Ye YC, Yang JM, Cheng Y. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020, 10(4): 1833-1848. doi: 10.7150/thno.39814.
Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X*, Yin M*. Occupational Skin Conditions on the Front Line: A Survey Among 484 Chinese Healthcare Professionals Caring for Covid-19 Patients. J Eur Acad Dermatol Venereol. 2020 Aug, 34(8): e354-e357. doi: 10.1111/jdv.16570.
Li LY, Chen XS, Wang KS, Guan YD, Ren XC, Cao DS, Sun XY, Li AX, Tao YG, Zhang Y, Yin MZ, Wang XL, Wu MH, Yang JM, Cheng Y. RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKα2-mediated autophagy. Oncogene. 2020, 39(43): 6704-6718. doi: 10.1038/s41388-020-01447-0.
Liao M, Zeng F, Li Y, Gao Q, Yin M, Deng G, Chen X. A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients. Sci Rep. 2020, 10(1): 12462. doi: 10.1038/s41598-020-69330-2.
Guo Y, Shen M, Zhang X, Xiao Y, Zhao S, Yin M, Bu W, Wang Y, Chen X, Su J. Association of Socioeconomic Changes due to the COVID-19 Pandemic With Health Outcomes in Patients With Skin Diseases: Cross-Sectional Survey Study. J Med Internet Res. 2020, 22(9): e22288. doi: 10.2196/22288.
Deng G#, Zeng F#, Su J, Zhao S, Hu R, Zhu W, Hu S, Chen X*, Yin M*. BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway. Theranostics. 2020 Sep 15, 10(25): 11428-11443. doi: 10.7150/thno.47432.
Guan Y, Jiang S, Ye W, Ren X, Wang X, Zhang Y, Yin M, Wang K, Tao Y, Yang J, Cao D, Cheng Y. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy. Cell Death Dis. 2020, 11(11): 948. doi: 10.1038/s41419-020-03153-x.
Yang SQ, Ye Q, Ding JJ, Yin MZ, Lu AP, Chen X, Hou TJ, Cao DS. Current advances in ligand-based target prediction. WIREs Comput Mol Sci. 2020, 1-21. doi: 10.1002/wcms.1504.
Jin L, Liu P, Yin M, Zhang M, Kuang Y, Zhu W. RIPK1: A rising star in inflammatory and neoplastic skin diseases. J Dermatol Sci. 2020, 99(3): 146-151. doi: 10.1016/j.jdermsci.2020.06.001.
Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020, 24(1): 179. doi: 10.1186/s13054-020-02902-w.
Liu P, Huang Z, Yin M, Liu C, Chen X, Pan P, Kuang Y. Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial. Trials. 2020, 21(1): 999. doi: 10.1186/s13063-020-04925-8.
Panchaud A, Favre G, Pomar L, Vouga M, Aebi-Popp K, Baud D; COVI-Preg group (Mingzhu Yin). An international registry for emergent pathogens and pregnancy. Lancet. 2020, 395(10235): 1483-1484. doi: 10.1016/S0140-6736(20)30981-8.
Ye Y, Kuang X, Xie Z, Liang L, Zhang Z, Zhang Y, Ma F, Gao Q, Chang R, Lee HH, Zhao S, Su J, Li H, Peng J, Chen H, Yin M, Peng C, Yang N, Wang J, Liu J, Liu H, Han L, Chen X. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1. Genome Med. 2020, 12(1): 83. doi: 10.1186/s13073-020-00780-z.
2019年
Hu B, Hu H, Yin M*, Sun Z, Chen X, Li Y, Sun Z, Liu C, Li L, Qiu Y*. Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain. Int J Cancer. 2019,144(3): 558-568. doi: 10.1002/ijc.31877.
Yin M, Zhou HJ, Lin C, Long L, Yang X, Zhang H, Taylor H, Min W*. CD34+ KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair. Cell Rep. 2019, 27(9): 2709-2724.e3. doi: 10.1016/j.celrep.2019.04.088.
2018年
Li J, Yin M, Song W, Cui F, Wang W, Wang S, Zhu H. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer. Cell Physiol Biochem. 2018, 45(1): 237-249. doi: 10.1159/000486770.
Long L, Yin M, Min W. 3D Co-culture System of Tumor-associated Macrophages and Ovarian Cancer Cells. Bio Protoc. 2018 Apr 20, 8(8): e2815. doi: 10.21769/BioProtoc.2815.
Han Z, Hu H, Yin M, Li X, Li J, Liu L, Liu B. miR-145 is critical for modulation of vascular smooth muscle cell proliferation in human carotid artery stenosis. J BIOL REG HOMEOS AG. 2018 May-Jun, 32 (3): 506-516.
2017年
Li L, Wei X, Wu B, Xiao Y, Yin M*, Yang Q*. siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells. ONCOL LETT. 2017, 13 (5): 3014-3024. doi: 10.3892/ol.2017.5828.
Zhang L, Fu Z, Li X, Tang H, Luo J, Zhang D, Zhuang Y, Han Z*, Yin M*. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway. CHEM BIOL DRUG DES. 2017, 90 (3): 450-455. doi: 10.1111/cbdd.12965.
Yang K, Xia B, Wang W, Cheng J, Yin M, Xie, H, Li, J, Ma, L, Yang, C, Li, A, Fan, X, Dhillon, HS, Hou, Y, Lou, G, Li, K. A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer. Sci Rep. 2017, 7: 43353. doi: 10.1038/srep43353.
Tan S, Feng B, Yin M, Zhou HJ, Lou G, Ji W, Li Y, Min W. Stromal Senp1 promotes mouse early folliculogenesis by regulating BMP4 expression. Cell Biosci. 2017, 7: 36. doi: 10.1186/s13578-017-0163-5.
Yin M, Zhou HJ, Zhang J, Lin C, Li H, Li X, Li Y, Zhang H, Breckenridge DG, Ji W, Min W. ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis. JCI Insight. 2017, 2 (18): e91828. doi: 10.1172/jci.insight.91828.
2016年
Yin MZ#, Tan S#, Li X, Hou Y, Cao G, Li K, Kou J, Lou G. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study. TUMOR BIOL. 2016, 37 (4): 5485-5492. doi: 10.1007/s13277-015-4164-x.
Cui CY, Sima J, Yin M, Michel M, Kunisada M, Schlessinger D. Identification of potassium and chloride channels in eccrine sweat glands. J Dermatol Sci. 2016, 81(2): 129-131. doi: 10.1016/j.jdermsci.2015.11.001.
Cao G, Ye X, Xu Y, Yin M, Chen H, Kou J, Yu B. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice. Drug Des Devel Ther. 2016, 10: 315-325. doi: 10.2147/DDDT.S96818.
Huang B#, Yin M#, Li X, Cao G, Qi J, Lou G, Sheng S, Kou J, Chen K, Yu B. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer. Oncotarget. 2016, 7(19): 27552-27566. doi: 10.18632/oncotarget.8487.
Fan L, Yin M, Ke C, Ge T, Zhang G, Zhang W, Zhou X, Lou G, Li K. Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer. J Cancer. 2016, 7 (10): 1265-1272. doi: 10.7150/jca.15074.
Zou S, Teixeira AM, Yin M, Xiang Y, Xavier-Ferrucio J, Zhang PX, Hwa J, Min W, Krause DS. Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation. Thromb Haemost. 2016,116(3): 506-516. doi: 10.1160/TH15-11-0848.
Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin M, Ma X, Zhou K, Qi J, Yu B, Kou J. Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway. Int J Mol Sci. 2016, 17(9): 1418. doi: 10.3390/ijms17091418.
Yin M#, Li X#, Tan S#, Zhou HJ, Ji W, Bellone S, Xu X, Zhang H, Santin AD, Lou G, Min W. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016, 126(11): 4157-4173. doi: 10.1172/JCI87252.
2015年
Ye Y#, Yin M#, Huang B, Wang Y, Li X, Lou G. CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer. Tumour Biol. 2015, 36(6): 4175-4179. doi: 10.1007/s13277-015-3052-8.
Ji W#, Li Y#, He Y#, Yin M#, Zhou HJ, Boggon TJ, Zhang H, Min W. AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis. CANCER RES. 2015, 75 (17): 3492-3504. doi: 10.1158/0008-5472.CAN-15-0088.
2014年
Cui CY, Yin M, Sima J, Childress V, Michel M, Piao Y, Schlessinger D. Involvement of Wnt, Eda and Shh at defined stages of sweat gland development. Development. 2014, 141(19): 3752-60. doi: 10.1242/dev.109231.
Hou Y#, Yin M#, Sun F, Zhang T, Zhou X, Li H, Zheng J, Chen X, Li C, Ning X, Lou G, Li K. A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients. Mol Biosyst. 2014, 10(8): 2126-33. doi: 10.1039/c4mb00054d.
Ge T, Yin M, Yang M, Liu T, Lou G. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1. Cell Physiol Biochem. 2014, 34(6): 2209-2220. doi: 10.1159/000369664.
2013年
Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, Zhang W, Zhang H, Zhao F, Zhou X, Lou G, Li K. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J Proteome Res. 2013, 12(1): 505-512. doi: 10.1021/pr3009572.
Yin M#, Hou Y#, Zhang T, Cui C, Zhou X, Sun F, Li H, Li X, Zheng J, Chen X, Li C, Ning X, Li K, Lou G. Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: a prospective cohort study. PLoS One. 2013, 8(1): e54969. doi: 10.1371/journal.pone.0054969.
2012年
Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac.
Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao F, Zhang W, Ke C, Zhang G, Hou Y, Zhou X, Lou G, Li K. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry. Clin Chim Acta. 2012 May 18;413(9-10):861-8. doi: 10.1016/j.cca.2012.01.026.
Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, Sun M, Li Z, Hou Y, Zhou X, Lou G, Li K. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform. Acta Oncol. 2012 Apr; 51(4): 473-9. doi: 10.3109/0284186X.2011.648338.
Kang Y, Yin M, Jiang W, Zhang H, Xia B, Xue Y, Huang Y. Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma. Am J Surg. 2012 Nov;204(5):677-83. doi: 10.1016/j.amjsurg.2012.02.003.
Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, Lou G, Li K. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. J Surg Oncol. 2012 Feb;105(2):206-11. doi: 10.1002/jso.22052.
2011年
Meng F, Song H, Luo C, Yin M, Xu Y, Liu H, Zhou R, Lou G. Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer. 2011 Jun 15;117(12):2652-8. doi: 10.1002/cncr.25833.
Yin M, Li C, Li X, Lou G, Miao B, Liu X, Meng F, Zhang H, Chen X, Sun M, Ling Q, Zhou R. Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol. 2011 Jul 1;104(1):29-36. doi: 10.1002/jso.21912.
Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011 Jan;21(1):92-9. doi: 10.1111/IGC.0b013e3181fe8b6e.
Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689.
2010年
Meng F, Luo C, Hu Y, Yin M, Lin M, Lou G, Zhou R. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study. Int J Gynecol Pathol. 2010 Nov;29(6):587-93. doi: 10.1097/PGP.0b013e3181e0898e.
Meng FL, Yin MZ, Song HT, Yang H, Lou G, Zhou RL. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Int J Gynecol Cancer. 2010 Jul;20(5):745-50. doi: 10.1111/IGC.0b013e3181e02f90.
发表中文论文10篇
卞小慧,印明柱*. EDA在少汗性外胚层发育不良的发病机制及Fc-EDA的治疗作用[J].皮肤科学通报, 2020, 37(1): 5. DOI: CNKI:SUN:ZYXW.0.2020-01-008.
杨巧红,张新江,杜清,李琳琳,蓝华全,吕依扬,黄舒蕾,印明柱*,魏小勇*. 胃癌靶向治疗机制及 中西医药物治疗情况的研究进展[J].转化医学电子杂志, 2018, 5(9): 9. DOI: CNKI:SUN:ZHDZ.0.2018-09-008.
夏百荣,印明柱,葛婷婷,卢北燕*,娄阁. Hepsin在卵巢上皮癌组织中的表达及其与预后的关系[J].中国妇产科临床杂志, 2013. DOI: CNKI:SUN:FKLC.0.2013-02-017.
印明柱,娄阁*,孙喜文. 血清蛋白指纹图谱检测在卵巢癌中应用研究进展[J].实用肿瘤学杂志, 2013, 27(002): 177-180. DOI: 10.3969/j.issn.1002-3070.2013.02.019.
陈秀玮,王丹云,刘佳,印明柱,娄阁,高颖,康熙熊,张广美*. 白桦脂酸对HeLa细胞的抑制作用及其机制研究[J].中国癌症杂志, 2012, 22(4): 5. DOI: 10.3969/j.issn.1007-3639.2012.04.003.
印明柱,娄阁*,陈秀玮,顾泰华. 新辅助化疗后根治性手术与同步放化疗在局部晚期宫颈癌的远期疗效评价[J].实用肿瘤学杂志, 2011, 25(1): 6. DOI: 10.3969/j.issn.1002-3070.2011.01.012.
王丹云,刘佳,印明柱,李雪婷,娄阁,刘运铎,陈秀玮*. 白桦酯醇诱导宫颈癌HeLa细胞凋亡及作用机制的研究[J].肿瘤, 2012, 32(4): 5. DOI:10.3781/j.issn.1109-0721.2012.04.002.
印明柱,刘伟,娄阁,夏百荣. 孕产期合并Krukenberg瘤一例报道[J].实用肿瘤学杂志, 2011, 25(3): 2. DOI: 10.3969/j.issn.1002-3070.2011.03.015.
刘珺珺,印明柱,李聪,娄阁. 阿米福汀联合腹腔灌注化疗治疗难治性及复发性卵巢癌疗效观察[J].亚太传统医药, 2011, 7(10): 3. DOI: CNKI:SUN:YTCT.0.2011-10-051.
印明柱,娄阁.新基因LAPTM4B与肿瘤[J].国际肿瘤学杂志, 2011, 38(1): 3. DOI: 10.3760/cma.j.issn.1673-422X.2011.01.004.